Amneal Pharmaceuticals, Inc. - News - Press Releases

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 23, 2013

Federal Appeals Court Ruling Affirms Amneal’s Green Light to Market New Esomeprazole Strontium Delayed-Release Capsules

Dec 17, 2013

Amneal Launches Esomeprazole Strontium 49.3 mg Delayed-release Capsules, a Pharmaceutical Alternative to Nexium®

Dec 03, 2013

Impax Laboratories Announces OxyContin® Patent Challenge Settlement

Nov 27, 2013

Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3

Nov 21, 2013

Impax Laboratories Launches Generic Solaraze® (Diclofenac Sodium Gel, 3%)

Nov 07, 2013

Generic Equivalent for Loestrin® 24 Fe Coming Soon

Nov 07, 2013

Impax Laboratories to Present at the 2013 Credit Suisse Healthcare Conference on November 14

Nov 04, 2013

Impax Laboratories Reports Third Quarter 2013 Results

Oct 30, 2013

Impax Laboratories and TOLMAR, Inc. Announce Final FDA Approval for Generic Solaraze® Gel (Diclofenac Sodium-3%)

Oct 25, 2013

Impax Laboratories Confirms Patent Challenge Relating to Generic Atelvia® Delayed-Release Tablets, 35 mg

Oct 08, 2013

Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2013 Financial Results

Sep 30, 2013

Amneal Pharmaceuticals to Acquire Four Generic Products

Aug 13, 2013

Impax Laboratories to Present at the Canaccord Genuity Annual Growth Conference

Aug 08, 2013

Impax Laboratories Reports Second Quarter 2013 Results

Aug 02, 2013

Amneal Pharmaceuticals Announces Five New Oral Solids

Jul 15, 2013

Impax Laboratories Launches Authorized Generic TRILIPIX® Delayed Release Capsules, 45 mg and 135 mg

Jul 09, 2013

Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2013 Financial Results

Jul 05, 2013

Mary K. Pendergast Appointed to Impax Laboratories Board of Directors

Jul 03, 2013

Impax Laboratories Confirms Patent Challenge Relating to Generic TOVIAZ® 4 mg and 8 mg

Jun 25, 2013

Dr. Larry Hsu, Impax Laboratories President and Chief Executive Officer, to Retire

Jun 05, 2013

Impax Laboratories Announces Reduction in Workforce

Jun 03, 2013

Impax Laboratories to Present at the Jefferies Global Healthcare Conference

May 24, 2013

Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference

May 20, 2013

Impax Board of Directors Establishes Compliance Committee

May 20, 2013

Impax Laboratories to Present at the UBS Global Healthcare Conference

May 17, 2013

Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.

May 10, 2013

Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

May 01, 2013

Impax Laboratories Reports First Quarter 2013 Results

Apr 29, 2013

Impax Pharmaceuticals and GlaxoSmithKline Terminate Their Collaboration on IPX066 (RYTARYTM)

Apr 03, 2013

Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2013 Financial Results

Mar 19, 2013

Impax Pharmaceuticals Announces Presentation of RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data at the American Academy of Neurology 2013 Annual Meeting

Mar 15, 2013

RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data to be Presented at the American Academy of Neurology Conference

Mar 04, 2013

Impax Provides an Update on FDA Inspection of Hayward Facility

Mar 01, 2013

Impax Laboratories to Present at the Cowen & Company 33rd Annual Health Care Conference

Feb 25, 2013

Amneal Gets Approval for Generic Suboxone®

Feb 25, 2013

Impax Laboratories Reports Fourth Quarter and Full Year 2012 Results

Feb 08, 2013

Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR®

Jan 28, 2013

Amneal Partners With Hanmi to Market Nexium® Alternative

Jan 21, 2013

FDA Issues Complete Response Letter for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application

Jan 17, 2013

Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2012 Financial Results

Jan 04, 2013

Impax Laboratories Launches Oxymorphone Hydrochloride Extended-Release Tablets

Jan 02, 2013

Impax Laboratories to Present at the 31st Annual J.P. Morgan Healthcare Conference

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14